AUO [AU OPTRONICS] 6-K: Item 1. Press release entitled, AU Optronics Corp.
[Item 1. Press release entitled, AU Optronics Corp. Reports November 2012 Consolidated Revenue dated December 7, 2012. AU Optronics Corp.]
AUO [AU OPTRONICS] 6-K: (Original Filing)
[Item 1. AU Optronics Corp.]
MPEL [Melco Crown Entertainment] 6-K: (Original Filing)
[Melco Crown Entertainment Limited (Incorporated in the Cayman Islands with limited liability) (Stock Code: 6883) ANNOUNCEMENT PROPOSED ACQUISITION OF INTEREST IN MANCHESTER INTERNATIONAL HOLDINGS UNLIMITED CORPORATION Melco Crown Entertainment Company Buyers Acquisition Agreement MIH PSE Proposed Acquisition Melco Crown Entertainment Limited ( INTRODUCTION The Company is pleased to announce that the Buyers have entered into the Acquisition Agreement with the]
AUO [AU OPTRONICS] 6-K: Item 1. AU Optronics Corp.
[Item 1. AU Optronics Corp.]
MPEL [Melco Crown Entertainment] 6-K: Melco Crown Entertainment Limited (Incorporated in the Cayman
[Melco Crown Entertainment Limited (Incorporated in the Cayman Islands with limited liability) (Stock Code: 6883) ANNOUNCEMENT PROPOSED ACQUISITION OF INTEREST IN MANCHESTER INTERNATIONAL HOLDINGS UNLIMITED CORPORATION Melco Crown Entertainment Company Buyers Acquisition Agreement MIH PSE Proposed Acquisition Melco Crown Entertainment Limited ( INTRODUCTION The Company is pleased to announce that the Buyers have entered into the Acquisition Agreement with the]
TPI [TIANYIN PHARMACEUTICAL] POS AM: Post Effective Amendment No.4 to FORM S-1 REGISTRATION
[Post Effective Amendment No.4 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 20-4857782 (I.R.S. Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 Renmin Road South, Chengdu, P. R. China, 610041 +0086-28-86154737 Dr. Guoqing Jiang Chief Executive Officer Tianyin Pharmaceutical Co.,] [HUNTER TAUBMAN WEISS LLP 17 State Street, Suite 2000 New York, New York 10007 (212) 732-7184 Fax: (212) 202-6380 E-mail: LTaubman@htwlaw.com December 7, 2012 Tianyin Pharmaceutical Co., Inc. 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 Ladies and Gentlemen: In so acting, we have examined and relied upon the originals or] [Patrizio & Zhao, LLC Certified Public Accountants and Consultants 322 Route 46 West Parsippany, NJ 07054 Fax: (973) 882-0788 www.pzcpa.com Member of Alliance of worldwide accounting firms CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in the Post-Effective Amendment No. 4 to a Registration Statement on Form S-1 pertaining to the registration of 15,784,640 shares of]
SSW [Seaspan] FWP: (Original Filing)
[Registration No. 333-168938 SUMMARY OF FINAL TERMS December 6, 2012 $67,500,000 SEASPAN CORPORATION 7.95% SERIES D CUMULATIVE REDEEMABLE PERPETUAL PREFERRED SHARES This summary pricing sheet relates only to the securities described below and should only be read together with the Preliminary Prospectus Supplement, subject to completion, dated December 5, 2012, relating to these securities and supersedes the information in the]
SSW [Seaspan] FWP: Registration No. 333-168938 SUMMARY OF FINAL TERMS December
[Registration No. 333-168938 SUMMARY OF FINAL TERMS December 6, 2012 $67,500,000 SEASPAN CORPORATION 7.95% SERIES D CUMULATIVE REDEEMABLE PERPETUAL PREFERRED SHARES This summary pricing sheet relates only to the securities described below and should only be read together with the Preliminary Prospectus Supplement, subject to completion, dated December 5, 2012, relating to these securities and supersedes the information in the]
